§ 13F · FUND PROFILE
TCG Crossover Management, LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 43Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$3021.7T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 7.11M | $959.0T | 31.7% | NEW |
| 2 | COGT | COGENT BIOSCIENCES INC | 5.87M | $208.4T | 6.9% | NEW |
| 3 | CGON | CG ONCOLOGY INC | 3.67M | $152.4T | 5.0% | NEW |
| 4 | TNGX | TANGO THERAPEUTICS INC | 12.76M | $113.1T | 3.7% | NEW |
| 5 | CNTA | CENTESSA PHARMACEUTICALS PLC | 4.29M | $107.2T | 3.5% | NEW |
| 6 | DYN | DYNE THERAPEUTICS INC | 4.62M | $90.3T | 3.0% | NEW |
| 7 | RAPT | RAPT THERAPEUTICS INC | 2.58M | $87.5T | 2.9% | NEW |
| 8 | TYRA | TYRA BIOSCIENCES INC | 2.90M | $76.2T | 2.5% | NEW |
| 9 | AMLX | AMYLYX PHARMACEUTICALS INC | 6.24M | $75.4T | 2.5% | NEW |
| 10 | SVRA | SAVARA INC | 12.36M | $74.5T | 2.5% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE TCG SIGNAL
AC read
TCG Crossover Management, LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed